Page last updated: 2024-11-05

thiotepa and Bare Lymphocyte Syndrome

thiotepa has been researched along with Bare Lymphocyte Syndrome in 4 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PRAETORIUS, E1
LOPESCARDOZO, E1
IMANAGA, H1

Other Studies

4 other studies available for thiotepa and Bare Lymphocyte Syndrome

ArticleYear
CHEMOTHERAPY IN RETICULOSES.
    Proceedings of the Royal Society of Medicine, 1963, Volume: 56

    Topics: Chlorambucil; Cyclophosphamide; Genetic Diseases, X-Linked; Hodgkin Disease; Humans; Leukemia, Hairy

1963
[SURVIVAL TIME AND ABILITY TO WORK IN HEMOBLASTOSES TREATED BY CHEMOTHERAPY].
    Deutsches Archiv fur klinische Medizin, 1963, Dec-02, Volume: 209

    Topics: Antineoplastic Agents; Aziridines; Biomedical Research; Cyclophosphamide; Genetic Diseases, X-Linked

1963
[CYTOSTATIC THERAPY].
    Geneeskundige bladen uit kliniek en laboratorium voor de praktijk, 1964, Volume: 51

    Topics: Antineoplastic Agents; Breast Neoplasms; Busulfan; Chlorambucil; Colchicine; Cyclophosphamide; Femal

1964
[PREVENTION OF THE RECURRENCE OF CANCER].
    [Chiryo] [Therapy], 1964, Volume: 46

    Topics: Animals; Biomedical Research; Genetic Diseases, X-Linked; Hormones; Leukemia, Hairy Cell; Lymphatic

1964